Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection

Jan Münch, Elke Rücker, Ludger Ständker, +18

Cell

Human RetrovirusAntiviral ResponseVirologyProtein MisfoldingHiv +1

Contribution of Vpu, Env, and Nef to CD4 Down-Modulation and Resistance of Human Immunodeficiency Virus Type 1-Infected T Cells to Superinfection

Steffen Wildum, Michael Schindler, Jan Münch, +1

Journal of Virology

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

Zheng Zhou, Taishan Hu, Xue Zhou, +14

Scientific Reports

Mapping of mitochondrial mRNA termini in Arabidopsis thaliana : t-elements contribute to 5′ and 3′ end formation

Joachim Forner, Bärbel Weber, Sabine Thuss, +2

Nucleic Acids Research

A novel orally available small molecule that inhibits hepatitis B virus expression

H. Mueller, Steffen Wildum, Souphalone Luangsay, +21

Journal of Hepatology

Differential Regulation of NF-κB-Mediated Proviral and Antiviral Host Gene Expression by Primate Lentiviral Nef and Vpu Proteins

Daniel Sauter, Dominik Hotter, Benoît Van Driessche, +11

Cell Reports

<i>In Vitro</i> Evaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic Viruses

Manfred Marschall, Thomas Stamminger, Andreas Urban, +4

Antimicrobial Agents and Chemotherapy

Virus VariantsNeurovirologyAntiviral Drug DevelopmentAntiviral ResponseAntiviral Therapy +8

Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children

Jeffrey P. Baker, S. Block, Balpreet Matharu, +6

The Pediatric Infectious Disease Journal

VaccinationAntibioticsBaloxavir MarboxilInfluenza-infected ChildrenPediatrics +11

Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial

Deepali Kumar, Michael G. Ison, Jean‐Paul Mira, +12

The Lancet Infectious Diseases

Superiority TrialBaloxavir MarboxilAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy +4

PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA Stabilization

H. Mueller, Anaïs Lopez, Philipp Tropberger, +9

Hepatology